Featured Research

from universities, journals, and other organizations

New prognostic factor for early breast adenocarcinoma

Date:
March 25, 2010
Source:
American Journal of Pathology
Summary:
Scientists have discovered that high expression levels of delta-like ligand 4 (DLL4) predict poor prognosis in breast cancer.

Dr. Adrian L. Harris and colleagues at the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK have discovered that high expression levels of delta-like ligand 4 (DLL4) predict poor prognosis in breast cancer.

Related Articles


They present these findings in the April 2010 issue of the American Journal of Pathology.

Survival of patients with breast cancer is dependent on cancer stage, aggressiveness, and genetic makeup. New diagnostic markers that predict prognosis would therefore aid in therapeutic decision-making.

DLL4, a cell-signalling molecule expressed on endothelial cells, is regulated by the therapeutic target VEGF (vascular endothelial growth factor) as well as by low oxygen levels, suggesting that it plays possible roles in new blood vessel formation and growth in tumors. To explore the role of DLL4 in breast cancer, Jubb et al examined breast adenocarcinomas, normal breast tissues, and angiosarcomas. They found that DLL4 was expressed in endothelial cells within the tumor proper of breast adenocarcinomas, but not in normal non-lactating breast tissue, and that high expression levels of DLL4 predicted poor prognosis regarding both overall and relapse-free survival. Assessing which patients express DLL4 may therefore may be used to predict patients' responsiveness to anti-VEGF therapies.

Dr. Harris and colleagues "suggest that tumor endothelial expression of Dll4 is a significant prognostic factor in early breast adenocarcinoma." They believe "these data may have clinical relevance, as preclinical models suggest that assessing which patients express Dll4 in their tumor endothelium may be critical in predicting benefit from anti-VEGF therapies."

Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li J-L, Allen P, Leek R, Noguera-Troise I, Gatter KC, Thurston G, Harris AL: Expression of Vascular Notch Ligand Delta-like 4 (Dll4) and Inflammatory Markers in Breast Cancer. Am J Pathol 2010 176, 2019-2028


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Cite This Page:

American Journal of Pathology. "New prognostic factor for early breast adenocarcinoma." ScienceDaily. ScienceDaily, 25 March 2010. <www.sciencedaily.com/releases/2010/03/100325225519.htm>.
American Journal of Pathology. (2010, March 25). New prognostic factor for early breast adenocarcinoma. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/03/100325225519.htm
American Journal of Pathology. "New prognostic factor for early breast adenocarcinoma." ScienceDaily. www.sciencedaily.com/releases/2010/03/100325225519.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins